An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: A Gynecologic Oncology Group Study

被引:106
作者
Look, KY
Brunetto, VL
ClarkePearson, DL
Averette, HE
Major, FJ
Alvarez, RD
Homesley, HD
Zaino, RJ
机构
[1] INDIANA UNIV,SCH MED,DEPT OBSTET & GYNECOL,GYNECOL ONCOL SECT,INDIANAPOLIS,IN 46202
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK CANC INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[3] DUKE UNIV,SCH MED,DURHAM,NC 27710
[4] UNIV MIAMI,SCH MED,DIV GYNECOL ONCOL,JACKSON MEM MED CTR,MIAMI,FL 33136
[5] UNIV COLORADO,SCH MED,DENVER,CO 80203
[6] RUSH PRESBYTERIAN ST LUKES MED CTR,GYNECOL TUMOR SERV,DENVER,CO 80203
[7] UNIV ALABAMA,DEPT GYNECOL ONCOL,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35233
[8] CAROLINA GYNECOL ONCOL,DEPT OBSTET & GYNECOL,GYNECOL ONCOL SECT,WINSTON SALEM,NC 27103
[9] PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT PATHOL,HERSHEY,PA 17033
关键词
D O I
10.1006/gyno.1996.0327
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The influence of cell type on recurrence-free interval (RFI) and survival after radical hysterectomy for patients with Stage IB carcinoma of the cervix was investigated. Patients with Stage IB carcinoma of the cervix (>3-mm invasion) underwent a radical hysterectomy and pelvic lymphadenectomy. Patients with involved paraaortic nodes or gross extracervical disease were excluded. Of 813 evaluable patients, 645 had squamous, 104 with adenocarcinoma, and 64 had adenosquamous cell type. The time to failure and the following clinical/pathologic characteristics were compared among the three cell types: age, Gynecologic Oncology Group performance status (PS), gross versus occult tumor, histologic grade, depth of invasion, node status, uterine extension, parametrial extension, surgical margins, and capillary-lymphatic space (CLS) involvement. A Cox proportional hazards model was used to compare the patients with adenosquamous and adenocarcinoma to those with squamous while adjusting for prognostic factors. The median age was 40 years (range, 21-87). Pelvic nodes were involved in 119 (15%) of patients. There were no significant differences between cell types in distributions of the following factors: age, PS, positive nodes, depth of invasion, uterine extension, surgical margins, or parametrial extension. There were statistically significant differences between cell types with regards to grade (P <0.001), gross versus occult primary status (P=0.016), and CLS involvement (P=0.005). There was no statistically significant difference detected between cell types in crude comparisons of RFI (P=0.29); however, there was a difference in survival (P=0.02) with shorter survival seen in the adenosquamous cell type. After adjusting for CLS involvement, PS, depth of invasion, and clinical tumor size, survival remained worse for patients with adenosquamous primaries when compared to squamous carcinoma (P=0.02) and adenocarcinoma (P=0.007). In conclusion, no statistically significant differences were seen in RFI among cell types; however, in patients with Stage I carcinoma of the cervix overall survival after radical hysterectomy may be slightly worse for those with adenosquamous cell type. (C) 1996 Academic Press, Inc.
引用
收藏
页码:304 / 311
页数:8
相关论文
共 18 条
[1]   COMPARISON OF ADENOCARCINOMA AND SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX - A POPULATION-BASED EPIDEMIOLOGIC-STUDY [J].
ANTONCULVER, H ;
BLOSS, JD ;
BRINGMAN, D ;
LEEFELDSTEIN, A ;
DISAIA, P ;
MANETTA, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (05) :1507-1514
[2]  
BEREK JS, 1985, OBSTET GYNECOL, V65, P45
[3]  
Broders AC, 1926, ARCH PATHOL LAB MED, V2, P376
[4]  
Cox D. R., 1984, ANAL SURVIVAL DATA
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]   A PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF STAGE 1 SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
DELGADO, G ;
BUNDY, BN ;
FOWLER, WC ;
STEHMAN, FB ;
SEVIN, B ;
CREASMAN, WT ;
MAJOR, F ;
DISAIA, P ;
ZAINO, R .
GYNECOLOGIC ONCOLOGY, 1989, 35 (03) :314-320
[7]   ADENOCARCINOMA AS AN INDEPENDENT RISK FACTOR FOR DISEASE RECURRENCE IN PATIENTS WITH STAGE IB CERVICAL-CARCINOMA [J].
EIFEL, PJ ;
BURKE, TW ;
MORRIS, M ;
SMITH, TL .
GYNECOLOGIC ONCOLOGY, 1995, 59 (01) :38-44
[8]  
GALLUP DG, 1985, OBSTET GYNECOL, V65, P416
[9]   ADENOSQUAMOUS CARCINOMA OF THE CERVIX - PROGNOSIS IN EARLY-STAGE DISEASE TREATED BY RADICAL HYSTERECTOMY [J].
HARRISON, TA ;
SEVIN, BU ;
KOECHLI, O ;
NGUYEN, HN ;
AVERETTE, HE ;
PENALVER, M ;
DONATO, DM ;
NADJI, M .
GYNECOLOGIC ONCOLOGY, 1993, 50 (03) :310-315
[10]  
HOPKINS MP, 1991, OBSTET GYNECOL, V77, P912